BR112012030006A2 - composições farmacêuticas tópicas - Google Patents

composições farmacêuticas tópicas

Info

Publication number
BR112012030006A2
BR112012030006A2 BR112012030006A BR112012030006A BR112012030006A2 BR 112012030006 A2 BR112012030006 A2 BR 112012030006A2 BR 112012030006 A BR112012030006 A BR 112012030006A BR 112012030006 A BR112012030006 A BR 112012030006A BR 112012030006 A2 BR112012030006 A2 BR 112012030006A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
topical pharmaceutical
skin
compositions
psoriasis
Prior art date
Application number
BR112012030006A
Other languages
English (en)
Inventor
Christoph Willers
Fritjof Evers
Henning Mallwitz
Ricarda Meyer
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of BR112012030006A2 publication Critical patent/BR112012030006A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

composições farmacêuticas tópicas. a presente invenção refere-se a composições farmacêutcas tópicas compreendendo, com base no peso total da composição: a) 0,01 a 0,02% em peso de furoato de mometasona, b) 5 a 18% em peso de hexileno glicol, c) 20 a 40% em peso de água, e d) 25 a 70% em peso de uma fase oleosa. as referidas composições são estáveis e podem ser aplicadas com segurança e vacilidade a grandes áreas superficiais da pele de maneira aceitável pela população de pacientes em geral para o tratamento ou a prevenção de psoríase, dermatite atópica (eczema atópico) e outros distúrbios ou doenças de pele.
BR112012030006A 2010-05-26 2011-05-13 composições farmacêuticas tópicas BR112012030006A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10382146A EP2394653A1 (en) 2010-05-26 2010-05-26 Topical pharmaceutical compositions comprising mometasone furoate
US36505010P 2010-07-16 2010-07-16
PCT/EP2011/002369 WO2011147536A2 (en) 2010-05-26 2011-05-13 Topical pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BR112012030006A2 true BR112012030006A2 (pt) 2016-08-02

Family

ID=42797321

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012030006A BR112012030006A2 (pt) 2010-05-26 2011-05-13 composições farmacêuticas tópicas

Country Status (33)

Country Link
US (2) US20140200203A1 (pt)
EP (2) EP2394653A1 (pt)
JP (1) JP5743241B2 (pt)
KR (1) KR101790371B1 (pt)
CN (1) CN102883725B (pt)
AR (1) AR081765A1 (pt)
AU (1) AU2011257586B2 (pt)
BR (1) BR112012030006A2 (pt)
CA (1) CA2794553C (pt)
CL (1) CL2012003282A1 (pt)
CO (1) CO6640244A2 (pt)
DK (1) DK2575822T3 (pt)
EA (1) EA022967B1 (pt)
ES (1) ES2595250T3 (pt)
HK (1) HK1177893A1 (pt)
HR (1) HRP20161288T1 (pt)
HU (1) HUE029818T2 (pt)
IL (1) IL222163B (pt)
LT (1) LT2575822T (pt)
ME (1) ME02555B (pt)
MX (1) MX2012013642A (pt)
MY (1) MY160377A (pt)
NZ (1) NZ602730A (pt)
PL (1) PL2575822T3 (pt)
PT (1) PT2575822T (pt)
RS (1) RS55233B1 (pt)
SG (2) SG184405A1 (pt)
SI (1) SI2575822T1 (pt)
SM (1) SMT201600342B (pt)
TW (1) TWI473615B (pt)
UY (1) UY33404A (pt)
WO (1) WO2011147536A2 (pt)
ZA (1) ZA201208420B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate
KR20160030162A (ko) * 2013-07-11 2016-03-16 가부시키가이샤 폴라 파마 사용시 거품상을 나타내는 외용 조성물
GB2540764A (en) * 2015-07-24 2017-02-01 Fontus Health Ltd Topical composition
CN110770224B (zh) * 2017-03-10 2022-11-18 罗格斯新泽西州立大学 作为外排泵抑制剂的吲哚衍生物
EP3492068A1 (en) * 2017-12-01 2019-06-05 NCP NewCare Products GmbH Composition for treating onychomycosis
CN114767630A (zh) * 2022-06-06 2022-07-22 黑龙江中医药大学 一种治疗变应性鼻炎的药物组合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808610A (en) 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
WO1991008733A1 (en) 1989-12-20 1991-06-27 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
NZ278198A (en) 1993-12-21 1997-12-19 Schering Corp Pharmaceutical compositions comprising mometasone furoate and salicyclic acid; use in treatment of psoriasis
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
CA2305256C (en) 1997-10-09 2005-05-17 Schering Corporation Mometasone furoate suspensions for nebulization
TR200201343A2 (tr) 2002-05-17 2003-12-22 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve antiseptik içeren farmasötik bileşim
US7312207B2 (en) 2003-05-23 2007-12-25 Taro Pharmaceuticals North America, Inc. Topical steroid cream formulations
DE102006034883A1 (de) 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
WO2008126076A2 (en) 2007-04-11 2008-10-23 Perrigo Israel Pharmaceuticals Ltd. Low-dose mometasone formulations
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate

Also Published As

Publication number Publication date
JP5743241B2 (ja) 2015-07-01
TWI473615B (zh) 2015-02-21
IL222163B (en) 2018-01-31
EP2394653A1 (en) 2011-12-14
WO2011147536A3 (en) 2012-06-07
US9907807B2 (en) 2018-03-06
ME02555B (me) 2017-02-20
EP2575822B1 (en) 2016-07-06
EA201291335A1 (ru) 2013-04-30
CN102883725A (zh) 2013-01-16
CL2012003282A1 (es) 2013-01-25
UY33404A (es) 2011-12-01
ES2595250T3 (es) 2016-12-28
PT2575822T (pt) 2016-10-06
DK2575822T3 (en) 2016-10-17
CA2794553C (en) 2018-01-02
SMT201600342B (it) 2017-01-10
KR20130086137A (ko) 2013-07-31
AU2011257586B2 (en) 2014-04-17
PL2575822T3 (pl) 2017-01-31
CA2794553A1 (en) 2011-12-01
NZ602730A (en) 2014-03-28
CN102883725B (zh) 2015-04-01
AR081765A1 (es) 2012-10-17
CO6640244A2 (es) 2013-03-22
AU2011257586A1 (en) 2012-11-01
JP2013530149A (ja) 2013-07-25
HRP20161288T1 (hr) 2016-11-18
HUE029818T2 (en) 2017-04-28
EA022967B1 (ru) 2016-03-31
KR101790371B1 (ko) 2017-10-25
LT2575822T (lt) 2016-10-10
MX2012013642A (es) 2013-05-06
MY160377A (en) 2017-03-15
ZA201208420B (en) 2013-09-25
US20160038512A1 (en) 2016-02-11
RS55233B1 (sr) 2017-02-28
EP2575822A2 (en) 2013-04-10
SI2575822T1 (sl) 2016-11-30
SG184405A1 (en) 2012-11-29
SG10201502252YA (en) 2015-05-28
US20140200203A1 (en) 2014-07-17
TW201204367A (en) 2012-02-01
HK1177893A1 (zh) 2013-08-30
WO2011147536A2 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
BR112012030006A2 (pt) composições farmacêuticas tópicas
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
MX340250B (es) Espumas emolientes para el tratamiento de dermatosis.
UA111588C2 (uk) Композиція інгібітора jak для місцевого застосування
BR112016006926A2 (pt) composições compreendendo um conjugado de ácido quínico com ácido cafeico, usos terapêuticos e cosméticos
MX357168B (es) Formulacion topica para la piel.
IN2014KN01075A (pt)
BR112013008173A2 (pt) composições cosméticas para o cuidado com a pele
BR112015005339A8 (pt) uso de óleo de semente de fruta milagrosa como um ingrediente ativo
EA201401031A1 (ru) Полутвёрдая композиция для местного применения, которая содержит пирфенидон и модифицированный диаллилдисульфид оксид (m-ddo) для удаления или предупреждения угрей
BR112012019921A2 (pt) composições líquidas compreendendo um agente de resfriamento não-metol e um espessante para tratamento de um sintoma respiratório.
UA112420C2 (uk) Інгібітори апоптозу та їх застосування
BR112015004220A2 (pt) composições para o tratamento de psoríase
GEP20135900B (en) Emollient composition
BR112015001627A2 (pt) composição farmacêutica, respectivos usos e método para diminuir a frequência de micção
WO2012112232A8 (en) METHODS AND COMPOSITIONS FOR TREATING β-THALASSEMIA AND SICKLE CELL DISEASE
SG10201908690WA (en) Novel method of use and compositions
BR112015027436A8 (pt) composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos
BR112015012960A2 (pt) gel oral para o alívio da dor de dente
WO2012075093A3 (en) Topical formulations for administration of omega-3 fatty acids
BR112015015857A2 (pt) composição tópica e método de melhorar a microcirculação da pele
WO2012001082A3 (en) Moisturizing composition with spf 30
WO2011129627A3 (en) Docetaxel-loaded thermosensitive liquid suppository composition for rectal administration
MX2016008546A (es) Reduccion de queloides utilizando alantoina topica.
BR112013000296A2 (pt) agentes terapêuticos 976

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL